Related Experiment Video
Updated: Jun 24, 2026

11:15
HKUST-1 as a Heterogeneous Catalyst for the Synthesis of Vanillin
Published on: July 23, 2016
Total synthesis of (+)-11,11'-dideoxyverticillin A
Justin Kim1, James A Ashenhurst, Mohammad Movassaghi
1Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Summary
Researchers achieved the first total synthesis of the complex fungal alkaloid (+)-11,11'-dideoxyverticillin A. This breakthrough provides a new strategy for synthesizing related epidithiodiketopiperazine natural products.
Area of Science:
- Natural Product Chemistry
- Organic Synthesis
- Marine Microbiology
Background:
- The fungal metabolite (+)-11,11'-dideoxyverticillin A is a cytotoxic alkaloid.
- It belongs to the dimeric epidithiodiketopiperazine family, known for their structural complexity.
- Despite being known for decades, no member of this family has been synthesized totally.
Purpose of the Study:
- To achieve the first enantioselective total synthesis of (+)-11,11'-dideoxyverticillin A.
- To develop a synthetic strategy inspired by the proposed biosynthetic pathway.
- To establish a method for synthesizing other complex epidithiodiketopiperazines.
Main Methods:
- Enantioselective total synthesis strategy.
- Advanced-stage tetrahydroxylation and tetrathiolation reactions.
- Mild introduction of the epidithiodiketopiperazine core.
Main Results:
- A concise and enantioselective total synthesis of (+)-11,11'-dideoxyverticillin A was successfully accomplished.
- Highly stereo- and chemoselective reactions were developed for key transformations.
- A mild final step strategy for the sensitive epidithiodiketopiperazine core was established.
Conclusions:
- The total synthesis of (+)-11,11'-dideoxyverticillin A was achieved, overcoming a long-standing challenge.
- The developed synthetic strategy, inspired by biosynthesis, is effective for this alkaloid family.
- This work opens avenues for the synthesis of other complex dimeric epidithiodiketopiperazines.
Related Concept Videos
Biosynthesis in Bacteria
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.

